![Escalation scheme for 3+3 design with dose de-escalation (adapted from... | Download Scientific Diagram Escalation scheme for 3+3 design with dose de-escalation (adapted from... | Download Scientific Diagram](https://www.researchgate.net/publication/258385063/figure/fig1/AS:340181157728257@1458116916066/Escalation-scheme-for-3-3-design-with-dose-de-escalation-adapted-from-Lin-and-Shih-4.png)
Escalation scheme for 3+3 design with dose de-escalation (adapted from... | Download Scientific Diagram
![Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-021-01632-2/MediaObjects/41416_2021_1632_Fig1_HTML.png)
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer
![An overview of the BOIN design and its current extensions for novel early-phase oncology trials - ScienceDirect An overview of the BOIN design and its current extensions for novel early-phase oncology trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2451865422000606-gr2.jpg)
An overview of the BOIN design and its current extensions for novel early-phase oncology trials - ScienceDirect
![Interactive calculator for operating characteristics of phase I cancer clinical trials using standard 3+3 designs - ScienceDirect Interactive calculator for operating characteristics of phase I cancer clinical trials using standard 3+3 designs - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2451865418301017-gr1.jpg)
Interactive calculator for operating characteristics of phase I cancer clinical trials using standard 3+3 designs - ScienceDirect
![How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-018-0638-z/MediaObjects/12874_2018_638_Fig5_HTML.png)
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
![Moving Beyond 3+3: The Future of Clinical Trial Design | American Society of Clinical Oncology Educational Book Moving Beyond 3+3: The Future of Clinical Trial Design | American Society of Clinical Oncology Educational Book](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/edbk/2021/edbk.2021.41/edbk_319783/20210531/images/large/edbk_319783-table1.jpeg)
Moving Beyond 3+3: The Future of Clinical Trial Design | American Society of Clinical Oncology Educational Book
![Amazon | Dosage Form Design Parameters: Volume II (Advances in Pharmaceutical Product Development and Research) | Tekade PhD, Rakesh K. | Biological Sciences Amazon | Dosage Form Design Parameters: Volume II (Advances in Pharmaceutical Product Development and Research) | Tekade PhD, Rakesh K. | Biological Sciences](https://m.media-amazon.com/images/I/51dZXZ5JOOL._SX598_BO1,204,203,200_.jpg)